Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011
Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011
Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015
Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015
Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-6: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)
Figure 7-1: Global - Next Generation Sequencing Market (Billion US$), 2011-2015
Figure 7-2: Global - NGS Application by Sector (%)
Figure 7-3: Global - Next Generation Sequencing Market by Player (%), 2010
Figure 8-1: Abbott Laboratories - Revenue Breakup by Geography (%), 2011
Figure 8-2: Abbott Laboratories - Share of MDx Products in Diagnostics Revenue (2011)
Figure 8-3: Beckman Coulter - Revenue Breakup by Geography (%), 2010
Figure 8-4: Beckman Coulter - Revenue Breakup by Business Segment (%), 2010
Figure 8-5: Roche Holding - Diagnostic Division Revenue Breakup by Geography of (%), 2011
Figure 8-6: Roche Holding - Revenue Breakup by Diagnostics Division (%), 2011
Figure 8-7: Myriad Genetics - Revenue Breakup by Business Segment (%), 2012
Figure 8-8: Life Technologies - Revenue Breakup by Geography (%), 2011
Figure 8-9: Life Technologies - Revenue Breakup by Business Segment (%), 2011
Figure 8-10: Sequenom - Revenue Breakup by Business Segment (%), 2011
Figure 8-11: Transgenomic - Revenue Breakup by Geography (%), 2011
Figure 8-12: Transgenomic - Revenue Breakup by Business Segment (%), 2011
Figure 8-13: Dako - Revenue Breakup by Geography (%), 2011
Figure 8-14: Gen-Probe, Inc. - Revenue Breakup by Geography (%), 2011
Figure 8-15: Gen-Probe, Inc. - Revenue Breakup by Business Segment (%), 2011
Figure 8-16: Quest Diagnostics - Revenue Breakup by Business Segment (%), 2011

List of Tables:

Table 4-1: Genetic Testing Labs Penetration in Key Countries
Table 4-2: Key Companies in DTC Genetic Testing Segment
Table 5-1: Test Availability and Market Size for Key Conditions
Table 7-1: Listed Pharmacogenomic Biomarkers in FDA Approved Cancer Therapy Labels
Table 8-1: Abbott Molecular - Key Gene Based Product(s)
Table 8-2: Abbott Laboratories - Financial Performance (Million US$), 2009-2011
Table 8-3: Beckman Coulter - Key Gene Based Product(s)
Table 8-4: Beckman Coulter - Financial Performance (Million US$), 2008-2010
Table 8-5: Roche Molecular Diagnostics - Key Gene Based Product(s)
Table 8-6: Roche Holding - Financial Performance (Million US$), 2009-2011
Table 8-7: Myriad Genetics - Key Gene Based Product(s)
Table 8-8: Myriad Genetics - Financial Performance (Million US$), 2009-2012
Table 8-9: Life Technologies - Key Gene Based Product(s)
Table 8-10: Life Technologies - Financial Performance (Million US$), 2009-2011
Table 8-11: Genomic Health - Key Gene Based Product(s)
Table 8-12: Genomic Health - Financial Performance (Million US$), 2009-2011
Table 8-13: Sequenom - Key Gene Based Product(s)
Table 8-14: Sequenom - Financial Performance (Million US$), 2009-2011
Table 8-15: Transgenomic - Financial Performance (Million US$), 2009-2011
Table 8-16: Dako - Key Gene Based Product(s)
Table 8-17: Dako - Financial Performance (Million DKK), 2009-2011
Table 8-18: Gen-Probe, Inc. - Key Gene Based Product(s)
Table 8-19: Gen-Probe, Inc. - Financial Performance (Million US$), 2009-2011
Table 8-20: Quest Diagnostics - Key Gene Based Product(s)/Service(s)
Table 8-21: Quest Diagnostics - Financial Performance (Million US$), 2009-2011
Table 8-22: Genoptix - Key Gene Based Service(s)
Table 8-23: Genoptix - Financial Performance (Million US$), 2007-2009
Table 8-24: Clarient - Key Gene Based Service(s)
Table 8-25: Clarient - Financial Performance (Million US$), 2007-2009